0accd2f2da5320d30b0e921098d90e0e2cf8abf8
Template.md
| ... | ... | @@ -7,21 +7,11 @@ link-citations: true |
| 7 | 7 | |
| 8 | 8 | [[_TOC_]] |
| 9 | 9 | |
| 10 | -[[include:Overview.md]] |
|
| 10 | +[[include:Template_Overview.md]] |
|
| 11 | 11 | |
| 12 | -## History |
|
| 12 | +[[include:Template_History.md]] |
|
| 13 | 13 | |
| 14 | -[[include:History.md]] |
|
| 15 | - |
|
| 16 | -## Relevance tier by entity |
|
| 17 | - |
|
| 18 | -|Entity|Tier|Description | |
|
| 19 | -|:------:|:----:|--------------------------------------| |
|
| 20 | -| |1[@balSuperenhancerHypermutationAlters2022] |high-confidence DLBCL gene [@tanakaFrequentIncidenceSomatic1992]| |
|
| 21 | -| |1 |high-confidence FL gene| |
|
| 22 | -||2|relevance in PMBL/cHL/GZL not firmly established[@sarkozyMutationalLandscapeGray2021]| |
|
| 23 | -| |2 |relevance in BL not firmly established[@burkhardtClinicalRelevanceMolecular2022]| |
|
| 24 | - | |
|
| 14 | +[[include:Template_Relevance.md]] |
|
| 25 | 15 | |
| 26 | 16 | ## Mutation incidence in large patient cohorts (GAMBL reanalysis) |
| 27 | 17 |
Template_History.md
| ... | ... | @@ -0,0 +1,11 @@ |
| 1 | +## History |
|
| 2 | + |
|
| 3 | +```mermaid |
|
| 4 | +%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%% |
|
| 5 | +timeline |
|
| 6 | + title Publication timing |
|
| 7 | + 1992-01-01 : Tanaka : DLBCL |
|
| 8 | + 2011-07-27 : Morin : FL |
|
| 9 | + 2021-04-01 : Sarkozy : PMBL |
|
| 10 | + 2022-07-06 : Burkhardt : BL |
|
| 11 | +``` |
|
| ... | ... | \ No newline at end of file |
Template_Overview.md
| ... | ... | @@ -0,0 +1,5 @@ |
| 1 | +## Overview |
|
| 2 | + |
|
| 3 | +BCL2 mutations are frequently found in DLBCL, particularly in the germinal center B-cell (GCB) subtype, and are often located in the flexible loop domain and outside the BCL2-homology domains. |
|
| 4 | +These mutations are caused by the somatic hypermutation process. The presence of these mutations are strongly correlated with the presence of a translocation between BCL2 and one of the immunoglobulin loci. |
|
| 5 | +Although missense mutations may not be under positive selective pressure in the context of lymphomagenesis, some of these mutations may interfere with the function of BCL2 antagonists. |
Template_Relevance.md
| ... | ... | @@ -0,0 +1,9 @@ |
| 1 | +## Relevance tier by entity |
|
| 2 | + |
|
| 3 | +|Entity|Tier|Description | |
|
| 4 | +|:------:|:----:|--------------------------------------| |
|
| 5 | +| |1[@balSuperenhancerHypermutationAlters2022] |high-confidence DLBCL gene [@tanakaFrequentIncidenceSomatic1992]| |
|
| 6 | +| |1 |high-confidence FL gene| |
|
| 7 | +||2|relevance in PMBL/cHL/GZL not firmly established[@sarkozyMutationalLandscapeGray2021]| |
|
| 8 | +| |2 |relevance in BL not firmly established[@burkhardtClinicalRelevanceMolecular2022]| |
|
| 9 | + | |